Abstract

Background:Surgical removal remains the gold standard treatment for vestibular schwannomas (VS), but radiation therapy (RT) remains a viable alternative for small to medium-sized tumors with recent technological advances. Stereotactic radiosurgery (SRS) involves delivery of a high dose of radiation in a single treatment, while fractionated stereotactic radiotherapy (FSRT) involves 5 weeks of daily radiation treatment, with both utilizing a highly-targeted radiotherapy technique. Tumor control is excellent with any of the treatment approaches, with rates being reported at greater than 95% at 5 years.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.